Acta otorrinolaringologica espanola最新文献

{"title":"Venous by-pass (internal jugular vein-external jugular vein) in patient with bilateral radical neck dissection","authors":"Diego Tébar Calo , Pablo Verges Fort , Simon Brotons Durban , Ángel Pla Mocholi , Bosco Vendrell Marques","doi":"10.1016/j.otoeng.2024.10.002","DOIUrl":"10.1016/j.otoeng.2024.10.002","url":null,"abstract":"","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 2","pages":"Pages 130-133"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143384076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Postsurgical hypoparathyroidism: Identification of the high-risk patient. A comparison between the ATA protocol and the SEORL-CCC/SEEN consensus","authors":"Miriam García Lerma,&nbsp;Laura Rodrigáñez Riesco,&nbsp;Antonio del Palacio Muñoz,&nbsp;Ricardo Bernáldez Millán,&nbsp;Laura del Río Arroyo,&nbsp;Javier Gavilán Bouzas,&nbsp;Alejandro Castro Calvo","doi":"10.1016/j.otoeng.2024.10.003","DOIUrl":"10.1016/j.otoeng.2024.10.003","url":null,"abstract":"<div><h3>Introduction</h3><div>Parathyroid hormone (PTH) levels are the most reliable parameter to identify patients with a high risk of post-thyroidectomy hypoparathyroidism. The American Thyroid Association (ATA) developed a consensus where postoperative iPTH (PTHpost) &lt;15<!--> <!-->pg/mL suggests a significant risk for hypoparathyroidism. The Spanish Society of Otolaryngology and Head &amp; Neck Surgery (SEORL-CCC) identifies high-risk patients as those with a decrease of preoperative-postoperative PTH levels (PTHdecr) ≥80%. A comparison of the accuracy of both protocols is made.</div></div><div><h3>Materials and methods</h3><div>An analysis was conducted on all patients who underwent total or completion thyroidectomy over 10 years. A preoperative PTH (PTHpre) and a postoperative PTH (PTHpost) sample were collected. Postsurgical hypoparathyroidism was defined as the presence of hypocalcemia signs or symptoms, or calcium lower than 7<!--> <!-->mg/dL in serum levels or 0.95<!--> <!-->mmol/L in ionic levels. No patient received treatment without meeting our definition.</div></div><div><h3>Results</h3><div>711 patients were included. 19% of patients suffered from hypoparathyroidism. The PTHdecr demonstrated a ROC curve with an AUC of 0.98. iPTHpost demonstrated a ROC curve with an AUC of 0.97. The PTHdecr was found to have a statistically superior AUC compared to the PTHpost (p<!--> <!-->=<!--> <!-->0.002). Considering cutoff levels of 80% for iPTHdecr and 15<!--> <!-->pg/mL for PTHpost, no statistical differences were found between the sensitivity of both protocols (93% and 95% respectively), but the same cutoff levels showed a superior specificity of PTHdecr (95%) than PTHpost (86%).</div></div><div><h3>Conclusions</h3><div>SEORL-CCC protocol, which relies on PTHdecr, has demonstrated superior diagnostic accuracy. The cutoff level used showed a superior specificity without sacrificing its sensitivity.</div></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 2","pages":"Pages 99-105"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143426869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Complications after fine-needle aspiration cytology and core-needle biopsy in benign head & neck neoplasms","authors":"Alfonso Rodriguez-Urzay ,&nbsp;Maria Landa-Garmendia ,&nbsp;Jon Alexander Sistiaga-Suarez ,&nbsp;Jose Angel González-Garcá ,&nbsp;Ehkiñe Larruscain-Sarasola ,&nbsp;Mikel Beristain ,&nbsp;Carlos Miguel Chiesa-Estomba","doi":"10.1016/j.otoeng.2024.09.006","DOIUrl":"10.1016/j.otoeng.2024.09.006","url":null,"abstract":"<div><h3>Introduction</h3><div>Benign neck masses are one of the most common causes of clinical consultation in head &amp; neck (H&amp;N) clinics. Fine needle aspiration cytology (FNAC) and core needle biopsy (CNB) have become among the main strategies for the diagnostic work-up of palpable and non-palpable neck lumps. Moreover, numerous studies have established the safety, high diagnostic yield, and added value of image-guided H&amp;N biopsies, which play an important role in diagnosis, staging, and treatment planning, and can obviate the need for surgery for many patients. Nonetheless, despite the success of both techniques, there is a lack of recent studies regarding their safety and associated complication rates.</div></div><div><h3>Material &amp; method</h3><div>A retrospective analysis was performed of prospective data on patients undergoing ultrasound-guided FNAC or CNB for benign H&amp;N disease (e.g., salivary gland benign tumors, branchial cleft cyst, thyroglossal duct, cyst, lipoma, or neurinoma) between June 2016 and June 2021 in a tertiary university hospital.</div></div><div><h3>Results</h3><div>Overall, 192 patients were included (105 [54.7%] men and 87 [45.3%] women). The Kolmogorov-Smirnov test indicated that our data were normally distributed (<em>p</em> = 0.452). The mean age of enrolled patients was 54 ± 10 (range: 18–87). The anatomical site most commonly affected was a major salivary gland (74%). Regarding incidence and type of complications, nine (4.7%) patients experienced complications, infection being the most common problem. The risk of complications was highest in patients with branchial cleft cysts who had undergone FNAC (<em>p</em> = 0.028). Overall, the risk of complications was not associated with the type of technique (<em>p</em> =  0.603; OR: 0.942; 95% confidence interval = 0.245–3.624).</div></div><div><h3>Conclusion</h3><div>According to our results, FNAC and CNB are generally safe and reliable procedures in the diagnostic work-up of H&amp;N lumps. Nevertheless, physicians should be aware of certain risks associated with these procedures.</div></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 2","pages":"Pages 71-75"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142334130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bell's palsy and COVID-19: A cohort study with historical rate comparison","authors":"Natalia Arango ,&nbsp;María Jesús Rojas-Lechuga ,&nbsp;Jiwei Chen ,&nbsp;Francisco Larrosa ,&nbsp;Berta Alegre ,&nbsp;Isabel Vilaseca","doi":"10.1016/j.otoeng.2024.07.004","DOIUrl":"10.1016/j.otoeng.2024.07.004","url":null,"abstract":"<div><h3>Introduction</h3><div>During the SARS-CoV-2 pandemic, immune-mediated neurological events have been described in patients vaccinated against the virus or who have overcome the disease. Among these events is Idiopathic peripheral facial palsy or Bell’s palsy.</div></div><div><h3>Objectives</h3><div>To study the incidence of Bell's Palsy in the ENT emergency department of a tertiary hospital in Catalonia during the SARS-CoV-2 pandemic.</div></div><div><h3>Methods</h3><div>Retrospective historical cohort comparison study of patients diagnosed with Bell's palsy between January 2018 and December 2021. Crude incidence rates were calculated as the total number of events divided by person time at risk per 100.000 person-years. Observed (2020, 2021) and historical (2018, 2019) rates were compared using standardized incidence rates with corresponding 95% confidence intervals.</div></div><div><h3>Results</h3><div>Of the total number of ENT emergency department visits from 2018 to 2021 (22.658), there were 247 cases of Bell's palsy. The incidence rate of Bell's palsy in the pre-pandemic group was 12,2 and 10,9 per 100.000 person-years for 2018 and 2019, respectively. The 2020 standardized incidence rate of Bell's palsy was 0,70 [95% CI 0,49–1,01] and 1,25 [95% CI 0,93–1,67] for 2021. No significant differences were evident between the two groups.</div></div><div><h3>Conclusion</h3><div>In our cohort, no association was found between vaccination or COVID-19 infection and the development of Bell's Palsy.</div></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 1","pages":"Pages 31-36"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142303150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The new standardised nomenclature in Otorhinolaryngology by SEORL-CCC - ANAESTHESIA (SEDAR). Executive version 2024","authors":"Irene López Delgado ,&nbsp;Manuel Bernal-Sprekelsen","doi":"10.1016/j.otoeng.2024.04.002","DOIUrl":"10.1016/j.otoeng.2024.04.002","url":null,"abstract":"<div><h3>Purpose</h3><div>After the publication of the new standardized nomenclature for the specialty of Otorhinolaryngology in 2021, a joint adaptation was carried out with the Spanish Society of Anesthesiology, Resuscitation and Pain Therapy (SEDAR), creating an executive version. In this version, the Anesthesia groups are added for those procedures that require it and, in addition, the number of acts is reduced to facilitate its implementation in the daily basis healthcare activity. The aim of this article is to update the definitive executive version of the nomenclature for the specialty of Otolaryngology.</div></div><div><h3>Methods</h3><div>The nomenclature published in 2021 was updated, reducing the number of acts and procedures. For this purpose, a grouping of procedures similar in description and in order and ranking has been made. Those procedures that have been grouped together have received a new description that reflects all the acts included in order to facilitate its coding but respecting the essence of the proposal of the complete version of the 2021 nomenclature. Subsequently, the private medicine committee of SEDAR has assigned the anaesthetic act for those procedures that may require it. In addition, a provisional code has been assigned for those acts that are new with respect to the latest version approved by the OMC, which allows their numerical identification.</div></div><div><h3>Results</h3><div>The executive version of the nomenclature presents a total of 234 medical acts, compared to 395 listed in the 2021 version, which are distributed by OMC classification groups and ENT subspecialties. One-hundred and fourteen procedures maintain the original OMC code, with some modifications in the description of the medical act. Other procedures also performed by ENT but listed elsewhere were kept with their same description and group and assigned OMC codes. The remaining 120 procedures are new proposals made by the scientific society and its subspecialty committees.</div></div><div><h3>Conclusions</h3><div>The executive version of the new nomenclature of Otorhinolaryngology proposed by the SEORL-CCC and SEDAR updates the one from 2021 and is the only one valid in our specialty for its use in the private healthcare daily practice. The reduction of medical procedures, without losing richness or modifications of the surgical groups, and the allocation of the anesthesia scales, facilitates its implementation, and provides the highest standards of quality and clinical timelines.</div></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 1","pages":"Pages 37-49"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141140194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Real-world outcomes on quality-of-life improvement in patients with nasal polyposis treated with mepolizumab. RINOSUR study","authors":"Juan Maza-Solano ,&nbsp;Juan Aguilar-Cantador ,&nbsp;María Dolores Noguerol-Pérez ,&nbsp;María Soledad Sánchez-Torices ,&nbsp;María Jesús Martínez-Martínez ,&nbsp;María José Gámiz-Maroto","doi":"10.1016/j.otoeng.2024.08.001","DOIUrl":"10.1016/j.otoeng.2024.08.001","url":null,"abstract":"&lt;div&gt;&lt;div&gt;Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by nasal obstruction, reduced sense of smell, rhinorrhea, and facial pain for more than 12 weeks, significantly affecting quality of life (QoL), especially in patients with NSAID-exacerbated respiratory disease (NERD). Initial treatment includes intranasal corticosteroids and nasal irrigations, followed by systemic corticosteroids (SC) in severe cases, as well as endoscopic sinus surgery (ESS) and biological agents. Mepolizumab, a monoclonal antibody against IL-5, has been shown to reduce eosinophilic inflammation in CRSwNP. This study evaluates the improvement in quality of life of patients with CRSwNP treated with mepolizumab before December 2023, recorded by the RINOSUR group.&lt;/div&gt;&lt;div&gt;A retrospective observational multicenter cohort study is presented in adult patients with severe asthma and concomitant CRSwNP, treated with mepolizumab 100 mg. Variables such as sex, asthma, allergies, NERD, corticosteroid dependence, and serum eosinophil count were recorded. All patients underwent nasal endoscopy and completed the SNOT22 questionnaire. Therapeutic response was evaluated at 12 months.&lt;/div&gt;&lt;div&gt;Out of 143 patients recruited, only 28.6% had the necessary data. 61% were women with a mean age of 55 years. All were corticosteroid-dependent and had required at least one ESS. A 22% reduction in SC cycles was observed, and no patient required revision surgery in the 12 months following treatment. The SNOT22 score was reduced by 53 points, and serum eosinophilia also showed a significant decrease.&lt;/div&gt;&lt;div&gt;Mepolizumab is effective in treating severe uncontrolled CRSwNP, improving QoL and reducing dependence on systemic corticosteroids. Its activity is monitored by peripheral blood eosinophilia. Consistency in data collection is crucial to evaluate efficacy and manage the disease.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;La rinosinusitis crónica con pólipos nasales (RSCcPN) se caracteriza por obstrucción nasal, disminución del sentido del olfato, rinorrea y dolor facial durante más de 12 semanas, afectando significativamente la calidad de vida (CdV), especialmente en pacientes con enfermedad respiratoria exacerbada por AINEs (EREA). El tratamiento inicial comprende corticoides intranasales y lavados nasales, seguidos por corticoides sistémicos (CS) en casos severos, así como cirugía endoscópica nasosinusal (CENS) y fármacos biológicos. Mepolizumab, un anticuerpo monoclonal contra la IL-5, ha demostrado reducir la inflamación eosinofílica en RSCcPN. Este estudio evalúa la mejora en la calidad de vida de pacientes con RSCcPN tratados con mepolizumab antes de diciembre de 2023, registrado por el grupo RINOSUR.&lt;/div&gt;&lt;div&gt;Se presenta un estudio de cohorte retrospectivo observacional multicéntrico en pacientes adultos asmáticos graves con RSCcPN concomitante, tratados con mepolizumab 100 mg. Se registraron variables como sexo, asma, alergias, EREA, corticodependencia y recuento eosinofílico sérico. T","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 1","pages":"Pages 58-64"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142303157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transethmoidal meningoencephalocele: Endoscopic and radiological morphology","authors":"Ainhoa García-LLiberós ,&nbsp;Moisés Sánchez-Pardo ,&nbsp;Enrique Zapater-Latorre","doi":"10.1016/j.otoeng.2024.09.007","DOIUrl":"10.1016/j.otoeng.2024.09.007","url":null,"abstract":"","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 1","pages":"Pages 67-68"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142696080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Does the number of loops affect the results of barbed pharyngoplasties? A retrospective comparison in two techniques","authors":"Marina Carrasco Llatas ,&nbsp;Paula Martínez Ruiz de Apodaca ,&nbsp;Elena González Turienzo ,&nbsp;Miguel Martínez Moreno ,&nbsp;Felipe Domínguez Celis ,&nbsp;Giovanni Cammaroto ,&nbsp;Claudio Vicini","doi":"10.1016/j.otoeng.2024.07.003","DOIUrl":"10.1016/j.otoeng.2024.07.003","url":null,"abstract":"<div><h3>Introduction</h3><div>The use of barbed sutures for pharyngoplasty techniques is a new trend in sleep apnea surgery, but little is known about its short-term results depending on the different techniques. The purpose of this study was to analyse the surgical results in two different centres using barbed sutures with different barbed pharyngoplasty techniques.</div></div><div><h3>Material and methods</h3><div>This is a multicenter retrospective study of patients with obstructive sleep apnea (OSA) undergoing surgery, all of whom underwent pharyngoplasty with barbed suture using a classic or modified technique, which may or may not be associated with other surgical techniques. A univariate and multivariate statistical analysis were performed to assess the relationship of these surgical techniques with surgical success and with different descriptive variables.</div></div><div><h3>Results</h3><div>The final sample size was 126 patients. A surgical success rate of 39.7% was obtained for a postoperative AHI &lt; 10/h and a 51.6% success rate according to Sher's criteria. A greater proportion of success was observed in the modified barbed pharyngoplasty technique that was not maintained after the multivariate analysis, as with other factors such as age, ODI or the presence of nasal surgery.</div></div><div><h3>Conclusion</h3><div>Non-resective pharyngoplasty with barbed sutures is an effective technique for the treatment of OSA in selected patients, with both the classic technique and the modified alternatives having good postoperative results, with no differences observed in relation to surgical success between both. More studies are necessary to evaluate the differences between both techniques in more homogeneous groups.</div></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 1","pages":"Pages 25-30"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142303151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hemilarynx immobility in patient with syringomyelia","authors":"Alejandro Klein-Rodríguez","doi":"10.1016/j.otoeng.2024.07.001","DOIUrl":"10.1016/j.otoeng.2024.07.001","url":null,"abstract":"","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 1","pages":"Pages 50-52"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142303154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Laryngeal chondrosarcoma, a 30-year series","authors":"Patrícia Fernandes Lopes ,&nbsp;Joana Nascimento ,&nbsp;Gustavo Rocha ,&nbsp;Catarina Tinoco ,&nbsp;Ana Hebe ,&nbsp;Pedro Montalvão ,&nbsp;Miguel Magalhães","doi":"10.1016/j.otoeng.2024.09.004","DOIUrl":"10.1016/j.otoeng.2024.09.004","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Laryngeal chondrosarcoma is a rare laryngeal pathology arising from cartilaginous structures and is predominantly found in the cricoid cartilage. This study investigates its presentation, treatment modalities and patient outcomes.</div></div><div><h3>Patients or materials and methods</h3><div>Retrospective study of laryngeal chondrosarcoma cases followed from 1992 to 2022 in the Otorhinolaryngology department of a cancer center - Instituto Português de Oncologia de Lisboa. Statistical analysis was made with Microsoft Excel® and SPSS®.</div></div><div><h3>Results</h3><div>We identified 16 cases, of which two-thirds were male, with an average age of 59.6 years, and only 24% of them had a history of smoking. The commonest presentation was indolent dysphonia and/or dyspnea, and the posterior arch of the cricoid cartilage was the most affected place. Although histopathological studies after biopsy were often inconclusive, surgery emerged as the first-line of treatment for all patients. Larynx microsurgery with lesion debulking was the most frequent surgical approach (47%) followed by partial laryngectomy (24%). Neither adjuvant radiotherapy (RT) nor chemotherapy was administered in any of the cases. There was residual tumor in 23% of the cases so half of these patients were in watchful waiting while the other part underwent further microsurgery or total laryngectomy. Only one patient with recurrence received RT. Disease-specific survival rate at 1 and 5 years was 97% and 91%, respectively.</div></div><div><h3>Conclusion</h3><div>Laryngeal chondrosarcoma etiology is still unknown and is effectively treated with surgery, with a generally favorable prognosis. The main concern lies in its propensity to relapse, highlighting the importance of watchful follow-up.</div></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"76 1","pages":"Pages 20-24"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142303155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}